Complement 5a Receptor Antagonist [EPC]

Complement 5a Receptor Antagonist [EPC] was reported 6762 times

Drugs of the Complement 5a Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SPINAL ARTERY THROMBOSIS 3 0.1111
1 CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION 5 0.1111
2 RAOULTELLA ORNITHINOLYTICA INFECTION 8 0.1039
3 SUBGLOTTIC LARYNGITIS 2 0.0800
4 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 13 0.0774
5 SUSPECTED DRUG-INDUCED LIVER INJURY 15 0.0750
6 ABDOMINAL WALL PAIN 1 0.0588
7 VANISHING BILE DUCT SYNDROME 60 0.0538
8 INTERFERON GAMMA RELEASE ASSAY POSITIVE 6 0.0366
9 GRANULOMATOSIS WITH POLYANGIITIS 43 0.0356
10 ACTINOMYCES BACTERAEMIA 1 0.0345
11 MICROSCOPIC POLYANGIITIS 8 0.0309
12 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 73 0.0295
13 BILIRUBINURIA 3 0.0286
14 ALPHA 1 FOETOPROTEIN DECREASED 1 0.0250
15 LOWER URINARY TRACT SYMPTOMS 8 0.0221
16 DACRYOCYSTITIS 3 0.0195
17 EMPHYSEMATOUS CYSTITIS 4 0.0188
18 CARDIOMYOPATHY ACUTE 4 0.0183
19 BIOPSY KIDNEY 5 0.0175
20 PULMONARY VASCULITIS 9 0.0167
21 TRACHEAL STENOSIS 8 0.0158
22 RENAL VASCULITIS 5 0.0156
23 PORTAL FIBROSIS 3 0.0140
24 MONONEUROPATHY MULTIPLEX 6 0.0130
25 CYTOMEGALOVIRUS SYNDROME 2 0.0121
26 STEROID DIABETES 17 0.0113
27 BRONCHOSTENOSIS 6 0.0110
28 SERRATIA INFECTION 8 0.0107
29 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 12 0.0107
30 BLOOD TEST 2 0.0107
31 COMPLEMENT FACTOR C4 DECREASED 2 0.0104
32 DIALYSIS 145 0.0102
33 IMMOBILISATION SYNDROME 2 0.0094
34 INTENSIVE CARE 13 0.0091
35 PARANASAL SINUS INFLAMMATION 2 0.0090
36 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0089
37 REHABILITATION THERAPY 33 0.0085
38 EYE SYMPTOM 3 0.0084
39 RENAL TUBULAR ATROPHY 7 0.0079
40 ARTERIOVENOUS FISTULA OPERATION 2 0.0074
41 ALBUMIN GLOBULIN RATIO INCREASED 1 0.0073
42 INFUSION 3 0.0073
43 CARDIORENAL SYNDROME 4 0.0070
44 GALLBLADDER OEDEMA 2 0.0068
45 HOSPITALISATION 1026 0.0067
46 MIXED LIVER INJURY 20 0.0066
47 INTENTIONAL UNDERDOSE 47 0.0064
48 NEPHROSCLEROSIS 7 0.0063
49 PHAEOHYPHOMYCOSIS 3 0.0063
50 JC POLYOMAVIRUS TEST POSITIVE 7 0.0060
51 HERPES ZOSTER OTICUS 3 0.0059
52 GRAFT INFECTION 2 0.0059
53 VASCULITIS 68 0.0058
54 PHYSIOTHERAPY 3 0.0058
55 PULMONARY RENAL SYNDROME 2 0.0057
56 GRIEF REACTION 3 0.0057
57 GALLBLADDER ENLARGEMENT 6 0.0056
58 LEGIONELLA INFECTION 3 0.0052
59 LARYNGEAL STENOSIS 3 0.0052
60 B-LYMPHOCYTE COUNT DECREASED 7 0.0051
61 THERAPY INTERRUPTED 354 0.0049
62 MUSCLE ABSCESS 3 0.0048
63 PNEUMOCYSTIS JIROVECII PNEUMONIA 48 0.0048
64 GASTROINTESTINAL CANDIDIASIS 2 0.0048
65 HYPERAESTHESIA TEETH 6 0.0048
66 BICYTOPENIA 9 0.0046
67 OESOPHAGEAL INFECTION 2 0.0045
68 PRURITUS ALLERGIC 5 0.0043
69 IGA NEPHROPATHY 7 0.0042
70 KLEBSIELLA BACTERAEMIA 4 0.0042
71 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
72 PNEUMONIA BACTERIAL 38 0.0041
73 ANTIBIOTIC THERAPY 4 0.0041
74 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 3 0.0041
75 PNEUMONIA PNEUMOCOCCAL 6 0.0040
76 KIDNEY FIBROSIS 7 0.0040
77 SHUNT OCCLUSION 2 0.0039
78 CENTRAL NERVOUS SYSTEM VASCULITIS 2 0.0039
79 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0039
80 PLASMAPHERESIS 2 0.0038
81 HERPES ZOSTER DISSEMINATED 3 0.0037
82 PERIORBITAL CELLULITIS 2 0.0037
83 CHEMOTHERAPY 14 0.0037
84 GLOMERULONEPHRITIS 9 0.0037
85 DRUG-INDUCED LIVER INJURY 115 0.0037
86 ENDOTRACHEAL INTUBATION 10 0.0036
87 PULMONARY CAVITATION 3 0.0034
88 EPIDIDYMITIS 4 0.0034
89 RECTAL ULCER 4 0.0034
90 PULMONARY HAEMORRHAGE 26 0.0033
91 SUSPECTED OFF LABEL USE 15 0.0033
92 HEPATIC FUNCTION ABNORMAL 123 0.0033
93 PALLIATIVE CARE 5 0.0033
94 ABULIA 3 0.0032
95 CHOLESTATIC LIVER INJURY 7 0.0031
96 PNEUMONIA NECROTISING 2 0.0031
97 JAUNDICE 83 0.0031
98 MASTOIDITIS 3 0.0031
99 SUBCUTANEOUS EMPHYSEMA 3 0.0031
100 EMERGENCY CARE 9 0.0030
101 SURGICAL PROCEDURE REPEATED 2 0.0029
102 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
103 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
104 CYTOMEGALOVIRUS INFECTION 47 0.0028
105 LIVER DISORDER 125 0.0028
106 CYTOMEGALOVIRUS TEST POSITIVE 5 0.0028
107 MYCOBACTERIUM ABSCESSUS INFECTION 2 0.0028
108 PNEUMOMEDIASTINUM 5 0.0028
109 NONSPECIFIC REACTION 15 0.0027
110 HYPERTRANSAMINASAEMIA 19 0.0027
111 LIVER FUNCTION TEST INCREASED 56 0.0026
112 VEIN COLLAPSE 2 0.0026
113 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
114 COLON OPERATION 3 0.0025
115 JC VIRUS INFECTION 4 0.0025
116 PNEUMONIA LEGIONELLA 4 0.0025
117 SCLERITIS 4 0.0025
118 RENAL TRANSPLANT 9 0.0025
119 AMMONIA ABNORMAL 1 0.0025
120 HAEMATOLOGICAL INFECTION 6 0.0025
121 COMPRESSION FRACTURE 13 0.0024
122 LUNG OPERATION 2 0.0024
123 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
124 ENZYME LEVEL INCREASED 2 0.0024
125 BLOOD BILIRUBIN ABNORMAL 3 0.0023
126 CARDIAC OPERATION 20 0.0023
127 TREATMENT DELAYED 4 0.0023
128 PNEUMONIA FUNGAL 9 0.0023
129 STEROID DEPENDENCE 2 0.0023
130 IMPLANTABLE DEFIBRILLATOR INSERTION 3 0.0023
131 CYTOMEGALOVIRUS INFECTION REACTIVATION 10 0.0023
132 OESOPHAGEAL CANDIDIASIS 9 0.0023
133 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
134 BLOOD ALBUMIN INCREASED 2 0.0022
135 VOCAL CORD PARALYSIS 4 0.0022
136 HYPERVOLAEMIA 11 0.0022
137 PROTEIN URINE 2 0.0022
138 HEART TRANSPLANT 2 0.0022
139 CHOLESTASIS 42 0.0022
140 LIVING IN RESIDENTIAL INSTITUTION 4 0.0021
141 AUDITORY DISORDER 3 0.0021
142 COLITIS MICROSCOPIC 10 0.0021
143 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
144 PSEUDOMONAS INFECTION 17 0.0020
145 HYPOGAMMAGLOBULINAEMIA 13 0.0020
146 MARASMUS 3 0.0020
147 PNEUMONIA PSEUDOMONAL 3 0.0020
148 ARTHRITIS BACTERIAL 8 0.0019
149 NEUROMYOPATHY 2 0.0019
150 PROTEIN TOTAL INCREASED 5 0.0019
151 ALBUMINURIA 1 0.0019
152 STREPTOCOCCAL BACTERAEMIA 2 0.0018
153 OXYGEN THERAPY 3 0.0018
154 DEAFNESS NEUROSENSORY 6 0.0018
155 OESOPHAGEAL DISORDER 7 0.0018
156 SEBORRHOEIC DERMATITIS 3 0.0018
157 INFLAMMATORY MARKER INCREASED 9 0.0018
158 BRONCHOPULMONARY ASPERGILLOSIS 14 0.0018
159 HEPATIC CYTOLYSIS 23 0.0018
160 COVID-19 PNEUMONIA 21 0.0018
161 EXERCISE TOLERANCE DECREASED 10 0.0017
162 THERAPY CHANGE 17 0.0017
163 THYROIDECTOMY 3 0.0017
164 HOSPICE CARE 17 0.0017
165 PERFORMANCE STATUS DECREASED 8 0.0017
166 YELLOW SKIN 8 0.0017
167 PNEUMONIA INFLUENZAL 2 0.0017
168 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
169 HEPATIC ENZYME INCREASED 114 0.0017
170 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
171 CATHETER PLACEMENT 3 0.0016
172 THERAPY CESSATION 83 0.0016
173 FRACTURED SACRUM 2 0.0016
174 BACTERAEMIA 19 0.0016
175 SYSTEMIC CANDIDA 4 0.0016
176 BILE DUCT STONE 5 0.0016
177 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
178 DACRYOSTENOSIS ACQUIRED 2 0.0015
179 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
180 BILIARY OBSTRUCTION 2 0.0015
181 URINE ABNORMALITY 7 0.0015
182 PROTEIN TOTAL ABNORMAL 2 0.0015
183 EAR DISORDER 7 0.0015
184 HEPATITIS CHOLESTATIC 9 0.0015
185 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
186 CLUSTER HEADACHE 2 0.0015
187 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
188 LATENT TUBERCULOSIS 3 0.0014
189 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
190 INTENTIONAL DOSE OMISSION 40 0.0014
191 UNEVALUABLE EVENT 106 0.0014
192 MENINGITIS BACTERIAL 2 0.0014
193 MOUTH SWELLING 8 0.0014
194 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
195 ASPERGILLUS INFECTION 9 0.0014
196 ENDOCARDITIS 7 0.0014
197 CARDIAC FIBRILLATION 2 0.0014
198 COLONOSCOPY 3 0.0014
199 NORMOCYTIC ANAEMIA 2 0.0014
200 BLOOD CREATINE INCREASED 6 0.0014
201 THORACIC VERTEBRAL FRACTURE 4 0.0014
202 FAECES PALE 3 0.0013
203 NEURODERMATITIS 5 0.0013
204 MENTAL FATIGUE 2 0.0013
205 PHARYNGEAL SWELLING 13 0.0013
206 SERUM FERRITIN INCREASED 7 0.0013
207 INFECTIOUS PLEURAL EFFUSION 2 0.0013
208 EYELID DISORDER 3 0.0013
209 ALLERGIC COUGH 1 0.0013
210 GASTROSTOMY 2 0.0013
211 RENAL DISORDER 60 0.0013
212 BLOOD BLISTER 4 0.0013
213 PNEUMONIA VIRAL 4 0.0013
214 CUSHINGOID 4 0.0012
215 ABDOMINAL SYMPTOM 1 0.0012
216 MUSCLE DISORDER 10 0.0012
217 HEPATITIS ACUTE 8 0.0012
218 NEAR DEATH EXPERIENCE 4 0.0012
219 RESUSCITATION 2 0.0012
220 HEPATIC ENZYME ABNORMAL 6 0.0012
221 PRODUCT DOSE OMISSION IN ERROR 34 0.0012
222 BRAIN ABSCESS 3 0.0012
223 FOOD AVERSION 2 0.0012
224 ILLNESS 121 0.0012
225 CARDIAC PACEMAKER INSERTION 7 0.0012
226 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
227 PHYSICAL DECONDITIONING 3 0.0012
228 PROTEINURIA 22 0.0012
229 OCULAR ICTERUS 5 0.0012
230 ABSCESS DRAINAGE 1 0.0012
231 LARGE INTESTINE PERFORATION 8 0.0012
232 EXTREMITY NECROSIS 2 0.0011
233 CYTOPENIA 14 0.0011
234 IMMUNOSUPPRESSION 10 0.0011
235 GINGIVAL PAIN 9 0.0011
236 CHOLANGITIS 7 0.0011
237 HEPATOCELLULAR INJURY 16 0.0011
238 NASAL DISORDER 3 0.0011
239 PRODUCT SUPPLY ISSUE 8 0.0011
240 CARDIAC ABLATION 2 0.0011
241 OPHTHALMIC HERPES ZOSTER 2 0.0011
242 END STAGE RENAL DISEASE 20 0.0011
243 LUMBAR VERTEBRAL FRACTURE 5 0.0011
244 BODY TEMPERATURE ABNORMAL 2 0.0011
245 RENAL FUNCTION TEST ABNORMAL 5 0.0011
246 TRICHORRHEXIS 3 0.0011
247 MECHANICAL VENTILATION 2 0.0011
248 SURGERY 61 0.0010
249 PYELONEPHRITIS ACUTE 2 0.0010
250 COLOSTOMY 2 0.0010
251 MULTI-ORGAN DISORDER 2 0.0010
252 PRODUCT USE COMPLAINT 16 0.0010
253 HEPATITIS FULMINANT 3 0.0010
254 COVID-19 176 0.0010
255 HYPERPHAGIA 4 0.0010
256 INFECTION 145 0.0010
257 KLEBSIELLA INFECTION 5 0.0010
258 RENAL IMPAIRMENT 83 0.0010
259 UROSEPSIS 9 0.0010
260 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
261 LOWER RESPIRATORY TRACT INFECTION 44 0.0010
262 AORTIC DISSECTION 4 0.0010
263 BLOOD PRESSURE ABNORMAL 19 0.0010
264 URINARY BLADDER HAEMORRHAGE 2 0.0009
265 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
266 TESTICULAR PAIN 3 0.0009
267 PHARYNGEAL ERYTHEMA 2 0.0009
268 INCREASED APPETITE 18 0.0009
269 LIVER FUNCTION TEST ABNORMAL 27 0.0009
270 ACARODERMATITIS 1 0.0009
271 GASTROINTESTINAL ULCER 2 0.0009
272 INTERSTITIAL LUNG DISEASE 43 0.0009
273 HAEMATOCRIT INCREASED 2 0.0009
274 DISEASE COMPLICATION 4 0.0009
275 PULMONARY MASS 13 0.0009
276 RESPIRATION ABNORMAL 6 0.0009
277 PANCREATITIS NECROTISING 2 0.0009
278 GRANULOMA 3 0.0009
279 SINUS DISORDER 17 0.0009
280 SINUS PAIN 2 0.0009
281 BILIRUBIN CONJUGATED INCREASED 2 0.0009
282 HEPATOTOXICITY 19 0.0009
283 JAUNDICE CHOLESTATIC 3 0.0008
284 ASPARTATE AMINOTRANSFERASE INCREASED 45 0.0008
285 OXYGEN CONSUMPTION INCREASED 2 0.0008
286 OSTEOMYELITIS 15 0.0008
287 ASPIRATION 9 0.0008
288 AUTOIMMUNE DISORDER 8 0.0008
289 FUNGAL INFECTION 27 0.0008
290 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
291 IMPULSIVE BEHAVIOUR 3 0.0008
292 METASTASES TO PERITONEUM 2 0.0008
293 CHOLECYSTECTOMY 9 0.0008
294 DYSLIPIDAEMIA 4 0.0008
295 LOCALISED INFECTION 19 0.0008
296 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
297 HEPATITIS 20 0.0008
298 BLOOD BILIRUBIN INCREASED 21 0.0008
299 LUNG DISORDER 38 0.0008
300 RHINOVIRUS INFECTION 3 0.0008
301 HERNIA REPAIR 2 0.0008
302 HEPATITIS TOXIC 2 0.0008
303 KNEE ARTHROPLASTY 16 0.0008
304 PNEUMONIA 245 0.0008
305 ACROCHORDON 1 0.0008
306 SWELLING FACE 49 0.0008
307 AZOTAEMIA 3 0.0008
308 BLOOD POTASSIUM ABNORMAL 2 0.0007
309 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
310 PRODUCT SIZE ISSUE 4 0.0007
311 ARTERIOSCLEROSIS 7 0.0007
312 SHOULDER ARTHROPLASTY 2 0.0007
313 ULCER HAEMORRHAGE 5 0.0007
314 BLOOD CREATININE INCREASED 48 0.0007
315 ABSCESS ORAL 1 0.0007
316 ESCHERICHIA INFECTION 6 0.0007
317 ELECTRIC SHOCK SENSATION 2 0.0007
318 PAPULE 5 0.0007
319 LYMPHOPENIA 10 0.0007
320 CARDIAC FAILURE CHRONIC 3 0.0007
321 TENSION HEADACHE 3 0.0007
322 STAPHYLOCOCCAL INFECTION 23 0.0007
323 HYPERTONIC BLADDER 2 0.0007
324 HYPERTHYROIDISM 10 0.0007
325 IMMUNE SYSTEM DISORDER 9 0.0007
326 PNEUMONIA ASPIRATION 17 0.0007
327 HERPES ZOSTER 39 0.0007
328 BLOOD POTASSIUM INCREASED 11 0.0007
329 URINE ANALYSIS ABNORMAL 2 0.0007
330 TRANSFUSION 7 0.0007
331 OROPHARYNGEAL DISCOMFORT 6 0.0007
332 GANGRENE 4 0.0007
333 CENTRAL VENOUS CATHETERISATION 2 0.0007
334 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
335 AGE-RELATED MACULAR DEGENERATION 1 0.0007
336 CEREBRAL INFARCTION 16 0.0007
337 INSURANCE ISSUE 10 0.0007
338 DEVICE RELATED INFECTION 10 0.0006
339 NEPHROGENIC ANAEMIA 3 0.0006
340 BRAIN DEATH 2 0.0006
341 BACTERIAL INFECTION 12 0.0006
342 UMBILICAL HERNIA 3 0.0006
343 BLOOD CREATININE DECREASED 2 0.0006
344 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
345 FOREIGN BODY IN THROAT 2 0.0006
346 PNEUMOTHORAX 10 0.0006
347 BLOOD DISORDER 5 0.0006
348 INTESTINAL PERFORATION 7 0.0006
349 ENTEROCOCCAL INFECTION 3 0.0006
350 CHROMATURIA 14 0.0006
351 GASTROENTERITIS 9 0.0006
352 HERPES SIMPLEX 4 0.0006
353 LIVER INJURY 15 0.0006
354 HAEMOPTYSIS 17 0.0006
355 LEUKOPENIA 30 0.0006
356 MENINGITIS 4 0.0006
357 SEPSIS 66 0.0006
358 HIP FRACTURE 19 0.0006
359 ABDOMINAL DISCOMFORT 99 0.0006
360 EAR DISCOMFORT 6 0.0006
361 HEPATIC FIBROSIS 2 0.0006
362 APLASIA PURE RED CELL 2 0.0006
363 GASTROINTESTINAL DISORDER 52 0.0006
364 ACUTE SINUSITIS 1 0.0006
365 DROOLING 4 0.0006
366 BLOOD CREATININE ABNORMAL 2 0.0006
367 DEAFNESS 15 0.0006
368 SPINAL OPERATION 7 0.0006
369 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
370 PARAESTHESIA ORAL 8 0.0006
371 NEUTROPENIA 75 0.0006
372 BLOOD PHOSPHORUS DECREASED 2 0.0005
373 CEREBRAL DISORDER 4 0.0005
374 PRODUCT DOSE OMISSION ISSUE 158 0.0005
375 ERYTHEMA MULTIFORME 5 0.0005
376 PROTEIN TOTAL DECREASED 2 0.0005
377 PAROSMIA 4 0.0005
378 HYPERTENSION 112 0.0005
379 ADVERSE REACTION 7 0.0005
380 TROPONIN INCREASED 4 0.0005
381 HIP ARTHROPLASTY 8 0.0005
382 BOWEL MOVEMENT IRREGULARITY 4 0.0005
383 C-REACTIVE PROTEIN INCREASED 19 0.0005
384 UNDERDOSE 38 0.0005
385 HYPERVENTILATION 3 0.0005
386 ATRIOVENTRICULAR BLOCK 4 0.0005
387 EYE DISORDER 17 0.0005
388 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
389 DIZZINESS POSTURAL 5 0.0005
390 RENAL FAILURE 68 0.0005
391 PROCEDURAL HAEMORRHAGE 2 0.0005
392 BRAIN FOG 8 0.0005
393 LABORATORY TEST ABNORMAL 15 0.0005
394 NASAL DISCOMFORT 4 0.0005
395 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
396 APHONIA 7 0.0005
397 RESPIRATORY TRACT INFECTION 13 0.0005
398 GASTROENTERITIS VIRAL 9 0.0005
399 BLOOD TEST ABNORMAL 7 0.0005
400 INTRACRANIAL ANEURYSM 2 0.0005
401 HEPATIC FAILURE 15 0.0005
402 STENT PLACEMENT 4 0.0005
403 GALLBLADDER OPERATION 2 0.0005
404 TASTE DISORDER 10 0.0005
405 FLUID RETENTION 25 0.0005
406 ASPHYXIA 4 0.0005
407 PERIPHERAL SWELLING 75 0.0005
408 HYPERURICAEMIA 2 0.0005
409 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
410 HYPERKALAEMIA 17 0.0005
411 AGRANULOCYTOSIS 9 0.0005
412 SPINAL COMPRESSION FRACTURE 4 0.0005
413 ACUTE CORONARY SYNDROME 4 0.0005
414 HYPERBILIRUBINAEMIA 5 0.0005
415 GASTROINTESTINAL PERFORATION 2 0.0005
416 URINARY TRACT INFECTION 82 0.0005
417 DEATH 414 0.0005
418 BLOOD SODIUM DECREASED 9 0.0005
419 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
420 THROMBOSIS 38 0.0005
421 TONGUE DISCOMFORT 2 0.0005
422 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
423 ABSCESS LIMB 2 0.0005
424 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
425 PULMONARY THROMBOSIS 5 0.0005
426 IMMOBILE 2 0.0005
427 URINE OUTPUT DECREASED 4 0.0005
428 SARS-COV-2 TEST POSITIVE 6 0.0005
429 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
430 HEAD DISCOMFORT 8 0.0005
431 GASTROINTESTINAL INFECTION 4 0.0004
432 DIABETES MELLITUS 34 0.0004
433 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
434 PAPILLOEDEMA 2 0.0004
435 TOOTHACHE 8 0.0004
436 DISEASE RECURRENCE 21 0.0004
437 AGEUSIA 11 0.0004
438 HAEMATURIA 15 0.0004
439 EYE OPERATION 2 0.0004
440 IRON DEFICIENCY ANAEMIA 4 0.0004
441 DYSPHAGIA 41 0.0004
442 FORMICATION 3 0.0004
443 ROSACEA 2 0.0004
444 HEPATIC ENCEPHALOPATHY 4 0.0004
445 EPISTAXIS 32 0.0004
446 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
447 OFF LABEL USE 373 0.0004
448 PHOTOSENSITIVITY REACTION 7 0.0004
449 SKIN ABRASION 2 0.0004
450 FEBRILE NEUTROPENIA 28 0.0004
451 BLOOD URINE PRESENT 8 0.0004
452 DIARRHOEA 272 0.0004
453 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
454 DEEP VEIN THROMBOSIS 27 0.0004
455 SEPTIC SHOCK 18 0.0004
456 OSTEOPOROSIS 17 0.0004
457 INFLUENZA 46 0.0004
458 NOCTURIA 5 0.0004
459 INCORRECT DOSAGE ADMINISTERED 2 0.0004
460 POLLAKIURIA 17 0.0004
461 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
462 TRANSAMINASES INCREASED 9 0.0004
463 HYPERNATRAEMIA 2 0.0004
464 PROTEIN URINE PRESENT 2 0.0004
465 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
466 HYPOAESTHESIA ORAL 6 0.0004
467 PRODUCT ADMINISTRATION ERROR 8 0.0004
468 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
469 HAEMATEMESIS 10 0.0004
470 AORTIC ANEURYSM 3 0.0004
471 TOE AMPUTATION 2 0.0004
472 BODY TEMPERATURE INCREASED 8 0.0004
473 AMMONIA INCREASED 2 0.0004
474 FEMORAL NECK FRACTURE 2 0.0004
475 SKIN DISORDER 13 0.0004
476 INCREASED UPPER AIRWAY SECRETION 2 0.0004
477 WHITE BLOOD CELL COUNT DECREASED 42 0.0004
478 TRISMUS 2 0.0004
479 ACTINIC KERATOSIS 1 0.0004
480 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
481 MULTIPLE ALLERGIES 3 0.0004
482 WEIGHT FLUCTUATION 4 0.0004
483 ORAL CANDIDIASIS 5 0.0004
484 BLOOD PRESSURE INCREASED 58 0.0004
485 PULMONARY CONGESTION 5 0.0004
486 EAR INFECTION 10 0.0004
487 JOINT INJURY 8 0.0004
488 UTERINE CANCER 3 0.0004
489 FOOD POISONING 2 0.0004
490 CHEILITIS 2 0.0004
491 HIP SURGERY 2 0.0004
492 HYPOXIA 13 0.0004
493 ABDOMINAL PAIN UPPER 76 0.0004
494 POST PROCEDURAL INFECTION 3 0.0004
495 DECUBITUS ULCER 3 0.0004
496 RESPIRATORY DISORDER 11 0.0004
497 HYDROCEPHALUS 2 0.0004
498 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
499 ACUTE HEPATIC FAILURE 5 0.0004
500 OSTEONECROSIS 12 0.0004
501 FAECALOMA 2 0.0004
502 ASTHENOPIA 2 0.0004
503 ACUTE RESPIRATORY FAILURE 7 0.0004
504 CHOKING SENSATION 2 0.0004
505 SINUSITIS 37 0.0004
506 DIVERTICULITIS 10 0.0004
507 EOSINOPHIL COUNT INCREASED 3 0.0004
508 NEPHROPATHY TOXIC 4 0.0004
509 ACUTE PULMONARY OEDEMA 2 0.0004
510 ABDOMINAL DISTENSION 37 0.0004
511 CHOLECYSTITIS ACUTE 2 0.0004
512 FLATULENCE 20 0.0004
513 HYPOPHAGIA 9 0.0004
514 ALOPECIA 69 0.0004
515 OEDEMA 19 0.0003
516 MICTURITION URGENCY 4 0.0003
517 INTERNAL HAEMORRHAGE 4 0.0003
518 GASTRIC HAEMORRHAGE 4 0.0003
519 FATIGUE 270 0.0003
520 ENTEROCOLITIS 2 0.0003
521 HYSTERECTOMY 3 0.0003
522 PYELONEPHRITIS 3 0.0003
523 ILL-DEFINED DISORDER 21 0.0003
524 STRESS CARDIOMYOPATHY 2 0.0003
525 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
526 BLOOD CALCIUM INCREASED 3 0.0003
527 HYPOVOLAEMIA 2 0.0003
528 PRODUCT USE ISSUE 64 0.0003
529 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
530 PERITONITIS 7 0.0003
531 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
532 IMMUNODEFICIENCY 5 0.0003
533 HYPERLIPIDAEMIA 4 0.0003
534 ADVERSE DRUG REACTION 30 0.0003
535 WRIST FRACTURE 4 0.0003
536 BLOOD PRESSURE FLUCTUATION 8 0.0003
537 ADRENAL INSUFFICIENCY 4 0.0003
538 GAIT INABILITY 11 0.0003
539 INGUINAL HERNIA 2 0.0003
540 DERMATITIS ACNEIFORM 2 0.0003
541 DECREASED APPETITE 76 0.0003
542 PULMONARY EMBOLISM 31 0.0003
543 PRODUCT DISTRIBUTION ISSUE 3 0.0003
544 DEMENTIA 9 0.0003
545 TOOTH EXTRACTION 4 0.0003
546 NEPHROPATHY 3 0.0003
547 INFUSION SITE EXTRAVASATION 2 0.0003
548 APPENDICITIS 3 0.0003
549 FLANK PAIN 3 0.0003
550 SECRETION DISCHARGE 4 0.0003
551 LUNG NEOPLASM MALIGNANT 13 0.0003
552 MUSCLE ATROPHY 4 0.0003
553 GASTRIC ULCER 6 0.0003
554 THERAPEUTIC RESPONSE CHANGED 2 0.0003
555 RESPIRATORY FAILURE 23 0.0003
556 FEELING JITTERY 6 0.0003
557 NAUSEA 249 0.0003
558 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
559 CYSTITIS 10 0.0003
560 ABSCESS 5 0.0003
561 POST PROCEDURAL COMPLICATION 6 0.0003
562 LOWER LIMB FRACTURE 6 0.0003
563 RASH 136 0.0003
564 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
565 INCOHERENT 2 0.0003
566 HAEMATOMA 8 0.0003
567 THROMBOTIC MICROANGIOPATHY 3 0.0003
568 BRADYPHRENIA 2 0.0003
569 KIDNEY INFECTION 6 0.0003
570 NO ADVERSE EVENT 55 0.0003
571 CORONAVIRUS INFECTION 2 0.0003
572 HYPOTONIA 3 0.0003
573 CARDIAC FAILURE ACUTE 2 0.0003
574 SKIN MASS 2 0.0003
575 SPINAL FRACTURE 6 0.0003
576 CARDIAC DISORDER 28 0.0003
577 CARDIAC FAILURE 24 0.0003
578 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
579 BLOOD UREA INCREASED 5 0.0003
580 LACRIMATION INCREASED 9 0.0003
581 ATRIAL FIBRILLATION 29 0.0003
582 PRODUCT PHYSICAL ISSUE 6 0.0003
583 EMPHYSEMA 3 0.0003
584 BRONCHIECTASIS 2 0.0003
585 CANDIDA INFECTION 5 0.0003
586 SUBARACHNOID HAEMORRHAGE 3 0.0003
587 PRODUCTIVE COUGH 14 0.0003
588 HEADACHE 183 0.0003
589 ECCHYMOSIS 2 0.0003
590 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
591 SKIN LESION 8 0.0003
592 TEMPERATURE INTOLERANCE 3 0.0003
593 POOR VENOUS ACCESS 3 0.0003
594 CHRONIC KIDNEY DISEASE 22 0.0003
595 LYMPHOEDEMA 2 0.0003
596 ENCEPHALITIS 2 0.0003
597 SWELLING 27 0.0003
598 SWOLLEN TONGUE 9 0.0003
599 AUTOIMMUNE HEPATITIS 2 0.0003
600 MOUTH ULCERATION 6 0.0003
601 SCRATCH 3 0.0003
602 DRUG ERUPTION 5 0.0003
603 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
604 OROPHARYNGEAL PAIN 26 0.0003
605 THIRST 5 0.0003
606 PARAESTHESIA 44 0.0003
607 INSOMNIA 74 0.0003
608 FAECES DISCOLOURED 6 0.0003
609 TONGUE DISORDER 2 0.0003
610 COUGH 77 0.0003
611 CHOLELITHIASIS 9 0.0003
612 WOUND INFECTION 3 0.0003
613 JOINT SWELLING 33 0.0003
614 GASTROINTESTINAL PAIN 3 0.0003
615 BLOOD GLUCOSE ABNORMAL 5 0.0003
616 URINARY RETENTION 9 0.0003
617 RASH MACULO-PAPULAR 6 0.0003
618 RENAL INJURY 8 0.0003
619 PULMONARY OEDEMA 12 0.0003
620 OXYGEN SATURATION DECREASED 15 0.0003
621 JOINT STIFFNESS 7 0.0003
622 EYE INFECTION 3 0.0003
623 FALL 88 0.0003
624 ACIDOSIS 2 0.0003
625 NEPHROLITHIASIS 12 0.0003
626 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
627 FEMUR FRACTURE 8 0.0003
628 APHTHOUS ULCER 2 0.0003
629 LIMB INJURY 7 0.0003
630 EAR PAIN 5 0.0003
631 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
632 PYREXIA 88 0.0003
633 BLOOD IRON DECREASED 3 0.0003
634 BLOOD ALBUMIN DECREASED 2 0.0003
635 INFLAMMATION 13 0.0003
636 CHOLECYSTITIS 3 0.0003
637 RASH ERYTHEMATOUS 12 0.0003
638 DYSPNOEA 142 0.0003
639 ATRIAL FLUTTER 2 0.0003
640 FRUSTRATION TOLERANCE DECREASED 2 0.0002
641 SHOCK HAEMORRHAGIC 2 0.0002
642 BLINDNESS 10 0.0002
643 NEUTROPHIL COUNT DECREASED 10 0.0002
644 ABNORMAL FAECES 2 0.0002
645 HYPOAESTHESIA 36 0.0002
646 VIRAL INFECTION 8 0.0002
647 LIP SWELLING 8 0.0002
648 CONDITION AGGRAVATED 73 0.0002
649 DRUG INTERACTION 38 0.0002
650 ADVERSE EVENT 22 0.0002
651 HYPOKALAEMIA 11 0.0002
652 OEDEMA PERIPHERAL 29 0.0002
653 COGNITIVE DISORDER 11 0.0002
654 CIRCULATORY COLLAPSE 4 0.0002
655 DIZZINESS 117 0.0002
656 MUSCULOSKELETAL DISCOMFORT 4 0.0002
657 HYPOACUSIS 10 0.0002
658 MUSCLE STRAIN 2 0.0002
659 CARDIAC ARREST 19 0.0002
660 RASH MACULAR 8 0.0002
661 INTENTIONAL PRODUCT MISUSE 20 0.0002
662 ANKYLOSING SPONDYLITIS 3 0.0002
663 VOMITING 107 0.0002
664 PRODUCT COMMUNICATION ISSUE 2 0.0002
665 ABDOMINAL ABSCESS 1 0.0002
666 MEMORY IMPAIRMENT 31 0.0002
667 RESPIRATORY RATE INCREASED 2 0.0002
668 SEIZURE 26 0.0002
669 PRURITUS 86 0.0002
670 RASH PAPULAR 5 0.0002
671 HAEMORRHAGE 23 0.0002
672 CELLULITIS 11 0.0002
673 ASTHENIA 82 0.0002
674 INCREASED TENDENCY TO BRUISE 2 0.0002
675 MALAISE 95 0.0002
676 BRONCHITIS 16 0.0002
677 HUNGER 3 0.0002
678 ANAEMIA 41 0.0002
679 HAEMOGLOBIN DECREASED 22 0.0002
680 BURNING SENSATION 15 0.0002
681 SKIN REACTION 3 0.0002
682 BLINDNESS UNILATERAL 3 0.0002
683 SQUAMOUS CELL CARCINOMA 2 0.0002
684 FRACTURE 4 0.0002
685 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
686 MUSCULAR WEAKNESS 24 0.0002
687 COLITIS 8 0.0002
688 FOOT FRACTURE 4 0.0002
689 SPUTUM DISCOLOURED 2 0.0002
690 NEUROPATHY PERIPHERAL 20 0.0002
691 GLAUCOMA 4 0.0002
692 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
693 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
694 ANOSMIA 3 0.0002
695 THROMBOCYTOPENIA 23 0.0002
696 PRESYNCOPE 5 0.0002
697 DYSSTASIA 6 0.0002
698 VITAMIN D DEFICIENCY 2 0.0002
699 ORAL HERPES 4 0.0002
700 HYPERSENSITIVITY 38 0.0002
701 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
702 KNEE OPERATION 2 0.0002
703 RASH PRURITIC 11 0.0002
704 MUSCLE SPASMS 37 0.0002
705 BLADDER DISORDER 2 0.0002
706 COLON CANCER 3 0.0002
707 CEREBROVASCULAR ACCIDENT 34 0.0002
708 THROAT IRRITATION 9 0.0002
709 HEART RATE DECREASED 7 0.0002
710 APHASIA 6 0.0002
711 FULL BLOOD COUNT DECREASED 4 0.0002
712 ARTHROPATHY 11 0.0002
713 FEEDING DISORDER 4 0.0002
714 PALPITATIONS 23 0.0002
715 SLUGGISHNESS 2 0.0002
716 FEELING HOT 12 0.0002
717 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
718 RIB FRACTURE 4 0.0002
719 ANKLE FRACTURE 3 0.0002
720 SKIN ULCER 5 0.0002
721 DYSPEPSIA 19 0.0002
722 ARTHRALGIA 80 0.0002
723 WEIGHT INCREASED 43 0.0002
724 SPEECH DISORDER 10 0.0002
725 DYSURIA 7 0.0002
726 NASOPHARYNGITIS 35 0.0002
727 PANCREATITIS 10 0.0002
728 FULL BLOOD COUNT ABNORMAL 2 0.0002
729 RESPIRATORY TRACT CONGESTION 3 0.0002
730 RENAL PAIN 2 0.0002
731 ULCER 3 0.0002
732 OBESITY 3 0.0002
733 EATING DISORDER 4 0.0002
734 NASAL CONGESTION 11 0.0002
735 CONTUSION 18 0.0002
736 SENSORY DISTURBANCE 3 0.0002
737 IRRITABLE BOWEL SYNDROME 4 0.0002
738 DRUG INTOLERANCE 18 0.0002
739 NIGHT SWEATS 6 0.0002
740 FREQUENT BOWEL MOVEMENTS 5 0.0002
741 BACK INJURY 2 0.0002
742 PRODUCT PRESCRIBING ISSUE 4 0.0002
743 CHEST PAIN 34 0.0002
744 TREATMENT NONCOMPLIANCE 10 0.0002
745 RESPIRATORY DISTRESS 5 0.0002
746 PLEURAL EFFUSION 11 0.0002
747 NERVE INJURY 2 0.0002
748 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
749 MALNUTRITION 2 0.0002
750 ORAL PAIN 4 0.0002
751 SKIN INFECTION 2 0.0002
752 TYPE 2 DIABETES MELLITUS 6 0.0002
753 OCULAR DISCOMFORT 2 0.0002
754 MIGRAINE 17 0.0002
755 FISTULA 2 0.0002
756 SCAB 2 0.0002
757 RED BLOOD CELL COUNT DECREASED 5 0.0002
758 TREMOR 29 0.0002
759 TINNITUS 8 0.0002
760 SKIN DISCOLOURATION 8 0.0002
761 SHOCK 4 0.0002
762 BALANCE DISORDER 15 0.0002
763 ORTHOSTATIC HYPOTENSION 3 0.0002
764 DYSKINESIA 7 0.0002
765 ELECTROLYTE IMBALANCE 2 0.0002
766 ABDOMINAL PAIN 40 0.0002
767 POST PROCEDURAL HAEMORRHAGE 2 0.0002
768 HEART RATE INCREASED 17 0.0002
769 RHINORRHOEA 11 0.0002
770 LYMPHOCYTE COUNT DECREASED 3 0.0002
771 VISUAL IMPAIRMENT 21 0.0002
772 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
773 ISCHAEMIC STROKE 3 0.0002
774 GALLBLADDER DISORDER 3 0.0002
775 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
776 ACCIDENT 2 0.0002
777 BLOOD POTASSIUM DECREASED 5 0.0002
778 ARTHRITIS 13 0.0002
779 CORONARY ARTERY DISEASE 5 0.0002
780 BURSITIS 2 0.0002
781 NEOPLASM MALIGNANT 11 0.0002
782 NEURALGIA 4 0.0002
783 ACUTE KIDNEY INJURY 25 0.0002
784 SMALL INTESTINAL OBSTRUCTION 2 0.0002
785 PHARYNGITIS 2 0.0002
786 HEPATIC STEATOSIS 3 0.0002
787 PANCYTOPENIA 9 0.0002
788 HEPATIC CIRRHOSIS 3 0.0002
789 PHOTOPHOBIA 3 0.0002
790 PLATELET COUNT DECREASED 17 0.0002
791 SOMNOLENCE 32 0.0002
792 ABDOMINAL PAIN LOWER 4 0.0002
793 COLITIS ULCERATIVE 7 0.0002
794 PULMONARY FIBROSIS 3 0.0002
795 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
796 FEELING ABNORMAL 37 0.0002
797 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
798 NODULE 2 0.0002
799 DEPRESSED MOOD 8 0.0002
800 HAEMATOCRIT DECREASED 3 0.0002
801 UPPER LIMB FRACTURE 3 0.0002
802 BLOOD PRESSURE DECREASED 10 0.0002
803 WEIGHT DECREASED 42 0.0002
804 SYNCOPE 15 0.0001
805 IRRITABILITY 9 0.0001
806 DISTURBANCE IN ATTENTION 8 0.0001
807 PERIPHERAL COLDNESS 2 0.0001
808 ORAL DISCOMFORT 2 0.0001
809 SKIN EXFOLIATION 12 0.0001
810 OSTEOARTHRITIS 6 0.0001
811 SEASONAL ALLERGY 2 0.0001
812 RETCHING 3 0.0001
813 CEREBRAL HAEMORRHAGE 5 0.0001
814 HYPERSOMNIA 4 0.0001
815 SKIN CANCER 3 0.0001
816 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
817 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
818 BLOOD GLUCOSE INCREASED 26 0.0001
819 MENTAL DISORDER 6 0.0001
820 ACUTE MYOCARDIAL INFARCTION 4 0.0001
821 CARDIOMYOPATHY 2 0.0001
822 EYE SWELLING 5 0.0001
823 CATARACT 8 0.0001
824 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
825 HEART RATE IRREGULAR 3 0.0001
826 DYSPNOEA EXERTIONAL 5 0.0001
827 HOT FLUSH 10 0.0001
828 PRODUCT AVAILABILITY ISSUE 3 0.0001
829 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
830 VERTIGO 8 0.0001
831 VISION BLURRED 18 0.0001
832 GAIT DISTURBANCE 25 0.0001
833 PERICARDIAL EFFUSION 3 0.0001
834 MUSCULOSKELETAL CHEST PAIN 2 0.0001
835 MENINGIOMA 2 0.0001
836 CHILLS 15 0.0001
837 SLEEP DISORDER 9 0.0001
838 DRY SKIN 17 0.0001
839 AFFECTIVE DISORDER 1 0.0001
840 OCULAR HYPERAEMIA 6 0.0001
841 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
842 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
843 DISORIENTATION 5 0.0001
844 MYALGIA 21 0.0001
845 MUSCLE TIGHTNESS 2 0.0001
846 DRY MOUTH 10 0.0001
847 BACK DISORDER 2 0.0001
848 AMNESIA 8 0.0001
849 IMPAIRED HEALING 4 0.0001
850 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
851 INFUSION RELATED REACTION 8 0.0001
852 HYPOTENSION 24 0.0001
853 PERICARDITIS 2 0.0001
854 ACNE 9 0.0001
855 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
856 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
857 LOSS OF CONSCIOUSNESS 15 0.0001
858 SCAR 2 0.0001
859 GASTRIC DISORDER 4 0.0001
860 RECTAL HAEMORRHAGE 5 0.0001
861 DIPLOPIA 3 0.0001
862 PAIN IN EXTREMITY 34 0.0001
863 NERVOUSNESS 6 0.0001
864 DISCOMFORT 7 0.0001
865 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
866 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
867 DEHYDRATION 15 0.0001
868 ERYTHEMA 23 0.0001
869 GOUT 2 0.0001
870 MOBILITY DECREASED 8 0.0001
871 THERAPY NON-RESPONDER 5 0.0001
872 THROAT TIGHTNESS 3 0.0001
873 LEUKOCYTOSIS 2 0.0001
874 PNEUMONITIS 3 0.0001
875 CONSTIPATION 24 0.0001
876 DRUG INEFFECTIVE 145 0.0001
877 RESTLESS LEGS SYNDROME 2 0.0001
878 INFLUENZA LIKE ILLNESS 9 0.0001
879 DYSGEUSIA 8 0.0001
880 URTICARIA 18 0.0001
881 PAIN 66 0.0001
882 THINKING ABNORMAL 2 0.0001
883 WOUND 3 0.0001
884 EYE PAIN 6 0.0001
885 HALLUCINATION 8 0.0001
886 PAIN IN JAW 3 0.0001
887 SLEEP APNOEA SYNDROME 2 0.0001
888 LETHARGY 6 0.0001
889 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
890 PRODUCT STORAGE ERROR 9 0.0001
891 DYSPHONIA 6 0.0001
892 HAEMORRHOIDS 2 0.0001
893 URINARY INCONTINENCE 3 0.0001
894 WHEEZING 6 0.0001
895 PRESCRIBED UNDERDOSE 2 0.0001
896 DRY EYE 5 0.0001
897 EPILEPSY 3 0.0001
898 LIMB DISCOMFORT 3 0.0001
899 RHABDOMYOLYSIS 4 0.0001
900 CARDIO-RESPIRATORY ARREST 4 0.0001
901 HALLUCINATION, VISUAL 2 0.0001
902 MOOD SWINGS 3 0.0001
903 HYPOTHYROIDISM 3 0.0001
904 IMPAIRED WORK ABILITY 2 0.0001
905 POOR QUALITY SLEEP 2 0.0001
906 MYOCARDIAL INFARCTION 16 0.0001
907 MELAENA 2 0.0001
908 HAEMATOCHEZIA 5 0.0001
909 ANGIOEDEMA 4 0.0001
910 BACK PAIN 21 0.0001
911 SNEEZING 2 0.0001
912 BLISTER 5 0.0001
913 HYPONATRAEMIA 5 0.0001
914 CARDIAC FAILURE CONGESTIVE 7 0.0001
915 DELIRIUM 3 0.0001
916 COMA 4 0.0001
917 MYELOSUPPRESSION 3 0.0001
918 MENTAL IMPAIRMENT 2 0.0001
919 STOMATITIS 5 0.0001
920 ACCIDENTAL OVERDOSE 3 0.0001
921 INTESTINAL OBSTRUCTION 3 0.0001
922 CARDIOVASCULAR DISORDER 2 0.0001
923 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
924 UNRESPONSIVE TO STIMULI 2 0.0001
925 ECZEMA 4 0.0001
926 DISEASE PROGRESSION 9 0.0001
927 BREAST CANCER 7 0.0001
928 FEAR 2 0.0001
929 CONFUSIONAL STATE 12 0.0001
930 PALLOR 2 0.0001
931 MOOD ALTERED 2 0.0001
932 RESPIRATORY ARREST 2 0.0001
933 ABNORMAL DREAMS 2 0.0001
934 TREATMENT FAILURE 6 0.0001
935 MENTAL STATUS CHANGES 2 0.0001
936 ROAD TRAFFIC ACCIDENT 3 0.0001
937 NECK PAIN 4 0.0001
938 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
939 HYPERHIDROSIS 9 0.0001
940 EYE IRRITATION 4 0.0001
941 ACCIDENTAL UNDERDOSE 1 0.0001
942 PANCREATIC CARCINOMA 2 0.0001
943 MUSCULOSKELETAL STIFFNESS 6 0.0001
944 CHEST DISCOMFORT 7 0.0001
945 ASCITES 2 0.0001
946 PSYCHOTIC DISORDER 2 0.0001
947 TACHYCARDIA 6 0.0001
948 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
949 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
950 SKIN IRRITATION 3 0.0001
951 EMOTIONAL DISORDER 2 0.0001
952 BLOOD CHOLESTEROL INCREASED 3 0.0001
953 NERVOUS SYSTEM DISORDER 2 0.0001
954 ARRHYTHMIA 3 0.0001
955 ANXIETY 18 0.0001
956 ASTHMA 7 0.0001
957 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
958 EXPIRED PRODUCT ADMINISTERED 2 0.0001
959 ANGER 2 0.0001
960 INJURY 4 0.0001
961 LYMPHADENOPATHY 2 0.0001
962 HYPERGLYCAEMIA 2 0.0001
963 PANIC ATTACK 2 0.0001
964 RESTLESSNESS 2 0.0001
965 ANAPHYLACTIC REACTION 3 0.0001
966 DYSARTHRIA 2 0.0001
967 BONE PAIN 3 0.0001
968 BLADDER CANCER 3 0.0001
969 ABNORMAL BEHAVIOUR 2 0.0001
970 EXTRA DOSE ADMINISTERED 2 0.0000
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
972 WITHDRAWAL SYNDROME 2 0.0000
973 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
974 VAGINAL HAEMORRHAGE 2 0.0000
975 INJECTION SITE PRURITUS 3 0.0000
976 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
977 DEPRESSION 10 0.0000
978 AGGRESSION 2 0.0000
979 INCORRECT DOSE ADMINISTERED 9 0.0000
980 PROSTATE CANCER 3 0.0000
981 RHEUMATOID ARTHRITIS 4 0.0000
982 EXPOSURE DURING PREGNANCY 2 0.0000
983 SKIN BURNING SENSATION 2 0.0000
984 OVERDOSE 6 0.0000
985 INJECTION SITE BRUISING 2 0.0000
986 TOXICITY TO VARIOUS AGENTS 4 0.0000
987 PSORIASIS 3 0.0000
988 EMOTIONAL DISTRESS 2 0.0000
989 AGITATION 1 0.0000
990 INJECTION SITE PAIN 3 0.0000